DONNA C ROSE M.D. NPI 1477696862

NPI Information

  • NPI: 1477696862
  • Provider Name: DONNA C ROSE, M.D.
  • Classification: Pathology - 207ZP0102X
  • Specialization: Anatomic Pathology & Clinical Pathology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: QUEST DIAGNOSTIC, INC.
    3 STERLING DRIVE
    WALLINGFORD, CT
    ZIP 06492
  • Phone: (203) 949-5580

Map and Directions

Get Directions

NPI Details

Donna C Rose, M.D. is an anatomic pathology and clinical pathology pathology in Wallingford, CT. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. Donna C Rose, M.D. NPI is 1477696862. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

QUEST DIAGNOSTIC, INC.
3 STERLING DRIVE
WALLINGFORD, CT
ZIP 06492
Phone: (203) 949-5580

The NPI 1477696862 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
  • Bacterial colony count, urine (HCPCS:87086)
  • Detection test by nucleic acid for multiple organisms, direct probe(s) technique (HCPCS:87800)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
  • Bacterial culture for aerobic isolates (HCPCS:87077)
  • Bacterial urine culture (HCPCS:87088)
  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
  • Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
  • Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Analysis for antibody, treponema pallidum (HCPCS:86780)
  • Pap test (HCPCS:88141)
  • Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
  • Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Vitamin d-3 level (HCPCS:82306)
  • Gonadotropin, follicle stimulating (reproductive hormone) level (HCPCS:83001)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Measurement of total estradiol (hormone) (HCPCS:82670)
  • Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Blood creatinine level (HCPCS:82565)
  • Identification of organisms by immunologic analysis, other than immunofluorescence method (HCPCS:87147)
  • Gonadotropin, luteinizing (reproductive hormone) level (HCPCS:83002)
  • Detection test for candida species (yeast), direct probe technique (HCPCS:87480)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Prolactin (milk producing hormone) level (HCPCS:84146)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique (HCPCS:87660)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Screening test for red blood cell antibodies (HCPCS:86850)
  • Blood group typing (abo) (HCPCS:86900)
  • Blood typing for rh (d) antigen (HCPCS:86901)
  • Detection test for gardnerella vaginalis (bacteria), direct probe technique (HCPCS:87510)
  • Calcium level, total (HCPCS:82310)
  • Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), agar dilution method (HCPCS:87181)
  • Analysis for antibody to rubella (german measles virus) (HCPCS:86762)
  • Analysis for antibody to herpes simplex virus, type 2 (HCPCS:86696)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • Analysis for antibody to herpes simplex virus, type 1 (HCPCS:86695)
  • Blood glucose (sugar) level after receiving dose of glucose (HCPCS:82950)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Dehydroepiandrosterone (dhea-s) hormone level (HCPCS:82627)
  • Analysis for antibody to varicella-zoster virus (chicken pox) (HCPCS:86787)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Hemoglobin a1c level (HCPCS:83036)
  • Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
  • Pap test, manual screening (HCPCS:88142)

The enumeration date for this NPI number is 2/15/2007 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207ZP0102XPathologyAnatomic Pathology & Clinical Pathology158495MASSACHUSETTSYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.